1. University of Cambridge, UK

Abstract

The apelin receptor (nomenclature as agreed by the NC-IUPHAR Subcommittee on the apelin receptor [73] and subsequently updated [75]) responds to apelin, a 36 amino-acid peptide derived initially from bovine stomach. apelin-36, apelin-13 and [Pyr¹]apelin-13 are the predominant endogenous ligands which are cleaved from a 77 amino-acid precursor peptide (APLN, Q9ULZ1) [88]. A second family of peptides discovered independently and named Elabela [13] or Toddler, that has little sequence similarity to apelin, is present, and functional at the apelin receptor in the adult cardiovascular system [97, 71]. The enzymatic pathways generating biologically active apelin and Elabela isoforms have not been determined but both propeptides include sites for potential proprotein convertase processing [81]. Structure-activity relationship Elabela analogues have been described [65, 90]. The stoichiometry of apelin receptor-heterotrimeric G protein complexes has been studied using cryogenic-electron microscopy [98].

Contents

GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a reference work which is most usefully represented as an on-line database. As in any publication this work should be appropriately cited, and the papers it cites should also be recognized. This document provides a citation for the relevant parts of the database, and also provides a reference list for the research cited by those parts. For further details see [8].

Please note that the database version for the citations given in GtoPdb are to the most recent preceding version in which the family or its subfamilies and targets were substantially changed. The links below are to the current version. If you need to consult the cited version, rather than the most recent version, please contact the GtoPdb curators.

Database links

References

1. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, Deng A, Eichhorn J, Mahajan R and Agrawal R et al.. (2005) The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 65: 73-82 [PMID:15621035]
2. Ason B, Chen Y, Guo Q, Hoagland KM, Chui RW, Fielden M, Sutherland W, Chen R, Zhang Y and Mihardja S et al.. (2020) Cardiovascular response to small-molecule APJ activation. JCI Insight 5 [PMID:32208384]
3. Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, Hiesinger W, Cohen JE and Joseph Woo Y. (2007) Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 12: 127-38 [PMID:17119870]
4. Azizi M, Iturrioz X, Blanchard A, Peyrard S, De Mota N, Chartrel N, Vaudry H, Corvol P and Llorens-Cortes C. (2008) Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol 19: 1015-24 [PMID:18272843]
5. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ and Woo YJ. (2004) Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110: II187-93 [PMID:15364861]
6. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B and Carpéné C et al.. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146: 1764-71 [PMID:15677759]
7. Brame AL, Maguire JJ, Yang P, Dyson A, Torella R, Cheriyan J, Singer M, Glen RC, Wilkinson IB and Davenport AP. (2015) Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist. Hypertension 65: 834-40 [PMID:25712721]
8. Buneman P, Christie G, Davies JA, Dimitrellou R, Harding SD, Pawson AJ, Sharman JL and Wu Y. (2020) Why data citation isn't working, and what to do about it Database 2020 [PMID:32367113]
9. Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O and Messele T et al.. (2000) Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. J Virol 74: 11972-6 [PMID:11090199]
10. Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV and Chen MM et al.. (2009) Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol 297: H1904-13 [PMID:19767528]
11. Chen N, Chen X, Chen Y, Cheng AC, Connors RV, Deignan J, Dransfield PJ, Du X, Fu Z and Heath JA et al.. (2016) Triazole agonists of the apj receptor Patent number: WO2016187308A1. Assignee: Amgen Inc.. Priority date: 20/05/2015. Publication date: 24/11/2016.
12. Cheng X, Cheng XS and Pang CC. (2003) Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol 470: 171-5 [PMID:12798955]
13. Chng SC, Ho L, Tian J and Reversade B. (2013) ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 27: 672-80 [PMID:24316148]
14. Choe W, Albright A, Sulcove J, Jaffer S, Hesselgesser J, Lavi E, Crino P and Kolson DL. (2000) Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. J Neurovirol 6 Suppl 1: S61-9 [PMID:10871767]
15. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, Zheng L, Leeper NJ, Pearl NE and Patterson AJ et al.. (2008) Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 118: 3343-54 [PMID:18769630]
16. Cox CM, D'Agostino SL, Miller MK, Heimark RL and Krieg PA. (2006) Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 296: 177-89 [PMID:16750822]
17. D'Aniello C, Lonardo E, Iaconis S, Guardiola O, Liguoro AM, Liguori GL, Autiero M, Carmeliet P and Minchiotti G. (2009) G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway. Circ Res 105: 231-8 [PMID:19574549]
18. Dai T, Ramirez-Correa G and Gao WD. (2006) Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553: 222-8 [PMID:17055480]
19. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Ayav A, Ziegler O, Carpene C and Saulnier-Blache JS et al.. (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20: 1528-30 [PMID:16723381]
20. De Mota N, Reaux-Le Goazigo A, El Messari S, Chartrel N, Roesch D, Dujardin C, Kordon C, Vaudry H, Moos F and Llorens-Cortes C. (2004) Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 101: 10464-9 [PMID:15231996]
21. Deng C, Chen H, Yang N, Feng Y and Hsueh AJ. (2015) Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling. J Biol Chem 290: 18261-8 [PMID:25995451]
22. Devic E, Rizzoti K, Bodin S, Knibiehler B and Audigier Y. (1999) Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 84: 199-203 [PMID:10473142]
23. El Messari S, Iturrioz X, Fassot C, De Mota N, Roesch D and Llorens-Cortes C. (2004) Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem 90: 1290-301 [PMID:15341513]
24. Fan X, Zhou N, Zhang X, Mukhtar M, Lu Z, Fang J, DuBois GC and Pomerantz RJ. (2003) Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ. Biochemistry 42: 10163-8 [PMID:12939143]
25. Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK, Marczin N, Szokodi I, Yacoub MH and Terracciano CM. (2007) Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 357: 889-95 [PMID:17466269]
26. Gargalovic P, Wong P, Onorato J, Finlay H, Wang T, Yan M, Crain E, St-Onge S, Héroux M and Bouvier M et al.. (2021) In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure. Circ Heart Fail 14: e007351 [PMID:33663236]
27. Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, Reaven GM, Quertermous T and Tsao PS. (2007) HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab 293: E1590-6 [PMID:17878221]
28. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, Kitada C, Nishizawa N, Murosaki S and Kurokawa T et al.. (1999) Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1452: 25-35 [PMID:10525157]
29. Hamada J, Kimura J, Ishida J, Kohda T, Morishita S, Ichihara S and Fukamizu A. (2008) Evaluation of novel cyclic analogues of apelin. Int J Mol Med 22: 547-52 [PMID:18813863]
30. Harford-Wright E, Andre-Gregoire G, Jacobs KA, Treps L, Le Gonidec S, Leclair HM, Gonzalez-Diest S, Roux Q, Guillonneau F and Loussouarn D et al.. (2017) Pharmacological targeting of apelin impairs glioblastoma growth. Brain 140: 2939-2954 [PMID:29053791]
31. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K, Kakuma T and Yoshimatsu H. (2007) Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148: 2690-7 [PMID:17347313]
32. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C, Honda S, Kurokawa T and Onda H et al.. (2000) Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 275: 21061-7 [PMID:10777510]
33. Hus-Citharel A, Bouby N, Frugière A, Bodineau L, Gasc JM and Llorens-Cortes C. (2008) Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 74: 486-94 [PMID:18509323]
34. Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R and Shiota N et al.. (2004) Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279: 26274-9 [PMID:15087458]
35. Iturrioz X, Alvear-Perez R, De Mota N, Franchet C, Guillier F, Leroux V, Dabire H, Le Jouan M, Chabane H and Gerbier R et al.. (2010) Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist. FASEB J 24: 1506-17 [PMID:20040517]
36. Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR, Sharma S, Neilson I, Webb DJ and Megson IL et al.. (2008) Vascular effects of apelin in vivo in man. J Am Coll Cardiol 52: 908-13 [PMID:18772060]
37. Jia YX, Pan CS, Zhang J, Geng B, Zhao J, Gerns H, Yang J, Chang JK, Tang CS and Qi YF. (2006) Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept 133: 147-54 [PMID:16278022]
38. Kasai A, Shintani N, Kato H, Matsuda S, Gomi F, Haba R, Hashimoto H, Kakuda M, Tano Y and Baba A. (2008) Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol 28: 1717-22 [PMID:18599802]
39. Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, Hinuma S and Baba A. (2004) Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325: 395-400 [PMID:15530405]
40. Katugampola SD, Maguire JJ, Matthewson SR and Davenport AP. (2001) [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 132: 1255-60 [PMID:11250876]
41. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O and Fujino M. (2001) Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538: 162-171 [PMID:11336787]
42. Khan P, Maloney PR, Hedrick M, Gosalia P, Milewski M, Li L, Roth GP, Sergienko E, Suyama E and Sugarman E et al.. (2011) Functional Agonists of the Apelin (APJ) Receptor. Probe Reports from the NIH Molecular Libraries Program [PMID:22834038]
43. Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T, Fujii R and Takakura N. (2008) Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 27: 522-34 [PMID:18200044]
44. Kleinz MJ and Davenport AP. (2005) Emerging roles of apelin in biology and medicine. Pharmacol Ther 107: 198-211 [PMID:15907343]
45. Kleinz MJ, Skepper JN and Davenport AP. (2005) Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 126: 233-40 [PMID:15664671]
46. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M and Fasshauer M. (2007) Growth hormone induces apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes. Regul Pept 139: 84-9 [PMID:17126924]
47. Kunduzova O, Alet N, Delesque-Touchard N, Millet L, Castan-Laurell I, Muller C, Dray C, Schaeffer P, Herault JP and Savi P et al.. (2008) Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J 22: 4146-53 [PMID:18708591]
48. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR and O'Dowd BF. (2000) Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74: 34-41 [PMID:10617103]
49. Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR and O'Dowd BF. (2005) Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146: 231-6 [PMID:15486224]
50. Li F, Li L, Qin X, Pan W, Feng F, Chen F, Zhu B, Liao D, Tanowitz H and Albanese C et al.. (2008) Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1. Front Biosci 13: 3786-92 [PMID:18508473]
51. Ma Y, Yue Y, Ma Y, Zhang Q, Zhou Q, Song Y, Shen Y, Li X, Ma X and Li C et al.. (2017) Structural Basis for Apelin Control of the Human Apelin Receptor. Structure 25: 858-866.e4 [PMID:28528775]
52. Macaluso NJ, Pitkin SL, Maguire JJ, Davenport AP and Glen RC. (2011) Discovery of a competitive apelin receptor (APJ) antagonist. ChemMedChem 6: 1017-23 [PMID:21560248]
53. Maguire JJ, Kleinz MJ, Pitkin SL and Davenport AP. (2009) [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension 54: 598-604 [PMID:19597036]
54. Maloney PR, Khan P, Hedrick M, Gosalia P, Milewski M, Li L, Roth GP, Sergienko E, Suyama E and Sugarman E et al.. (2012) Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor. Bioorg Med Chem Lett 22: 6656-60 [PMID:23010269]
55. Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC, Collins NB, Bi K, LaFleur MW and Juneja VR et al.. (2017) In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature 547: 413-418 [PMID:28723893]
56. Masri B, Knibiehler B and Audigier Y. (2005) Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 17: 415-26 [PMID:15601620]
57. Masri B, Lahlou H, Mazarguil H, Knibiehler B and Audigier Y. (2002) Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 290: 539-45 [PMID:11779205]
58. Masri B, Morin N, Cornu M, Knibiehler B and Audigier Y. (2004) Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18: 1909-11 [PMID:15385434]
59. Mazzucotelli A, Ribet C, Castan-Laurell I, Daviaud D, Guigné C, Langin D and Valet P. (2008) The transcriptional co-activator PGC-1alpha up regulates apelin in human and mouse adipocytes. Regul Pept 150: 33-7 [PMID:18501443]
60. McKeown SC, Zecri FJ, Fortier E, Taggart A, Sviridenko L, Adams CM, McAllister KH and Pin SS. (2014) The design and implementation of a generic lipopeptide scanning platform to enable the identification of 'locally acting' agonists for the apelin receptor. Bioorg Med Chem Lett 24: 4871-5 [PMID:25241924]
61. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G, Bolaky JE, Herrity NC, Murdock P and Darker JG. (2003) Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 84: 1162-1172 [PMID:12603839]
62. Meng W, Pi Z, Brigance R, Rossi KA, Schumacher WA, Bostwick JS, Gargalovic PS, Onorato JM, Luk CE and Generaux CN et al.. (2021) Identification of a Hydroxypyrimidinone Compound (21) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure. J Med Chem 64: 18102-18113 [PMID:34855405]
63. Miettinen KH, Magga J, Vuolteenaho O, Vanninen EJ, Punnonen KR, Ylitalo K, Tuomainen P and Peuhkurinen KJ. (2007) Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy. Regul Pept 140: 178-84 [PMID:17223209]
64. Mitra A, Katovich MJ, Mecca A and Rowland NE. (2006) Effects of central and peripheral injections of apelin on fluid intake and cardiovascular parameters in rats. Physiol Behav 89: 221-5 [PMID:16839572]
65. Murza A, Sainsily X, Coquerel D, Côté J, Marx P, Besserer-Offroy É, Longpré JM, Lainé J, Reversade B and Salvail D et al.. (2016) Discovery and Structure-Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions. J Med Chem 59: 2962-72 [PMID:26986036]
66. O'Carroll AM and Lolait SJ. (2003) Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraopric nuclei by osmotic stimuli. J Neuroendocrinol 15: 661-6 [PMID:12787050]
67. O'Carroll AM, Selby TL, Palkovits M and Lolait SJ. (2000) Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 1492: 72-80 [PMID:11004481]
68. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR and Nguyen T. (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136: 355-60 [PMID:8294032]
69. O'Shea M, Hansen MJ, Tatemoto K and Morris MJ. (2003) Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 6: 163-7 [PMID:12793520]
70. Patel SJ, Sanjana NE, Kishton RJ, Eidizadeh A, Vodnala SK, Cam M, Gartner JJ, Jia L, Steinberg SM and Yamamoto TN et al.. (2017) Identification of essential genes for cancer immunotherapy. Nature 548: 537-542 [PMID:28783722]
71. Pauli A, Norris ML, Valen E, Chew GL, Gagnon JA, Zimmerman S, Mitchell A, Ma J, Dubrulle J and Reyon D et al.. (2014) Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science 343: 1248636 [PMID:24407481]
72. Pi Z, Johnson JA, Meng W, Phillips M, Schumacher WA, Bostwick JS, Gargalovic PS, Onorato JM, Generaux CN and Wang T et al.. (2021) Identification of 6-Hydroxypyrimidin-4(1H)-one-3-carboxamides as Potent and Orally Active APJ Receptor Agonists. ACS Med Chem Lett 12: 1766-1772 [PMID:34795866]
73. Pitkin SL, Maguire JJ, Bonner TI and Davenport AP. (2010) International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacol Rev 62: 331-42 [PMID:20605969]
74. Read C, Fitzpatrick CM, Yang P, Kuc RE, Maguire JJ, Glen RC, Foster RE and Davenport AP. (2016) Cardiac action of the first G protein biased small molecule apelin agonist. Biochem Pharmacol 116: 63-72 [PMID:27475715]
75. Read C, Nyimanu D, Williams TL, Huggins DJ, Sulentic P, Macrae RGC, Yang P, Glen RC, Maguire JJ and Davenport AP. (2019) International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand. Pharmacol Rev 71: 467-502 [PMID:31492821]
76. Reaux A, De Mota N, Skultetyova I, Lenkei Z, El Messari S, Gallatz K, Corvol P, Palkovits M and Llorens-Cortès C. (2001) Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77: 1085-96 [PMID:11359874]
77. Reaux-Le Goazigo A, Morinville A, Burlet A, Llorens-Cortes C and Beaudet A. (2004) Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 145: 4392-400 [PMID:15166125]
78. Roberts EM, Newson MJ, Pope GR, Landgraf R, Lolait SJ and O'Carroll AM. (2009) Abnormal fluid homeostasis in apelin receptor knockout mice. J Endocrinol 202: 453-62 [PMID:19578099]
79. Roberts EM, Pope GR, Newson MJ, Landgraf R, Lolait SJ and O'Carroll AM. (2010) Stimulus-specific neuroendocrine responses to osmotic challenges in apelin receptor knockout mice. J Neuroendocrinol 22: 301-8 [PMID:20136689]
80. Salcedo A, Garijo J, Monge L, Fernández N, Luis García-Villalón A, Sánchez Turrión V, Cuervas-Mons V and Diéguez G. (2007) Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids. Regul Pept 144: 50-5 [PMID:17628718]
81. Shin K, Kenward C and Rainey JK. (2017) Apelinergic System Structure and Function. Compr Physiol 8: 407-450 [PMID:29357134]
82. Su S, Clarke A, Han Y, Chao HJ, Bostwick J, Schumacher W, Wang T, Yan M, Hsu MY and Simmons E et al.. (2019) Biphenyl Acid Derivatives as APJ Receptor Agonists. J Med Chem 62: 10456-10465 [PMID:31724863]
83. Sunter D, Hewson AK and Dickson SL. (2003) Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 353: 1-4 [PMID:14642423]
84. Susaki E, Wang G, Cao G, Wang HQ, Englander EW and Greeley Jr GH. (2005) Apelin cells in the rat stomach. Regul Pept 129: 37-41 [PMID:15927696]
85. Szokodi I, Tavi P, Földes G, Voutilainen-Myllylä S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysä J and Tóth M et al.. (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91: 434-40 [PMID:12215493]
86. Sörhede Winzell M, Magnusson C and Ahrén B. (2005) The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 131: 12-7 [PMID:15970338]
87. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, Ghatei M and Bloom S. (2002) The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 291: 1208-12 [PMID:11883945]
88. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S and Kitada C et al.. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471-6 [PMID:9792798]
89. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K and Fujimiya M. (2001) The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99: 87-92 [PMID:11384769]
90. Trân K, Murza A, Sainsily X, Delile E, Couvineau P, Côté J, Coquerel D, Peloquin M, Auger-Messier M and Bouvier M et al.. (2021) Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor. J Med Chem 64: 602-615 [PMID:33350824]
91. Tran K, Sainsily X, Côté J, Coquerel D, Couvineau P, Saibi S, Haroune L, Besserer-Offroy É, Flynn-Robitaille J and Resua Rojas M et al.. (2022) Size-Reduced Macrocyclic Analogues of [Pyr¹]-apelin-13 Showing Negative Gα₁₂ Bias Still Produce Prolonged Cardiac Effects. J Med Chem 65: 531-551 [PMID:34982553]
92. Valle A, Hoggard N, Adams AC, Roca P and Speakman JR. (2008) Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol 20: 79-84 [PMID:18081555]
93. Van Coillie E, Proost P, Van Aelst I, Struyf S, Polfliet M, De Meester I, Harvey DJ, Van Damme J and Opdenakker G. (1998) Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37: 12672-80 [PMID:9730840]
94. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E and Hsieh F et al.. (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277: 14838-43 [PMID:11815627]
95. Wei L, Hou X and Tatemoto K. (2005) Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept 132: 27-32 [PMID:16137778]
96. Yang P, Maguire JJ, Kuc RE, Siew K, Haris L, Torella R, Glen RC and Davenport AP. ELABELA/Toddler, a critical regulator of cardiac development, is expressed in the human cardiovascular system and binds the apelin receptor. https://bit.ly/2RpvLqB. Accessed on 07/07/2015.
97. Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, Upton PD, Crosby A, Sawiak SJ and Carpenter TA et al.. (2017) Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension. Circulation 135: 1160-1173 [PMID:28137936]
98. Yue Y, Liu L, Wu LJ, Wu Y, Wang L, Li F, Liu J, Han GW, Chen B and Lin X et al.. (2022) Structural insight into apelin receptor-G protein stoichiometry. Nat Struct Mol Biol 29: 688-697 [PMID:35817871]
99. Zhou N, Fan X, Mukhtar M, Fang J, Patel CA, DuBois GC and Pomerantz RJ. (2003) Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ. Virology 307: 22-36 [PMID:12667811]
100. Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K and Hoshino H. (2000) Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Lett 473: 15-8 [PMID:10802050]